Free tool
Diagnostics stocks
We cover 4 companies grouped under the Diagnostics theme. The median market value in the group is $74.75M. Across the group, the median move over the past trading day is 0.00%. Price change over the past year runs from −38.3% to −18.4% across the middle 80 percent of the group, with a median of −28.6%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
4 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| 0RAR.L | Stratec SE | $275.63M | Small cap | −14.98% |
| BVXP.L | Bioventix PLC | $124.26M | Small cap | −30.64% |
| RENX.L | Renalytix Plc | $25.24M | Micro cap | −26.50% |
| CNSL.L | Cambridge Nutritional Sciences plc | $6.14M | Micro cap | −41.54% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.